Cargando…

Thrombocytopenia and thrombocytosis are associated with different outcome in atrial fibrillation patients on anticoagulant therapy

BACKGROUND: Information regarding the significance of platelet (PLT) count on outcome of atrial fibrillation (AF) patients who are treated with anticoagulants is limited. METHODS: We conducted a monocentric observational retrospective cohort study of AF patients treated with either warfarin (n = 628...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michowitz, Yoav, Klempfner, Robert, Shlomo, Nir, Goldenberg, Ilan, Koren-Michowitz, Maya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837521/ https://www.ncbi.nlm.nih.gov/pubmed/31697741 http://dx.doi.org/10.1371/journal.pone.0224709

Ejemplares similares

QRS normalization during atrial pacing in a patient with complete left bundle branch block: What is your diagnosis?
por: Tovia-Brodie, Oholi, et al.
Publicado: (2015)

QT prolongation-related ventricular arrhythmia associated with atrial fibrillation electrical cardioversion
por: Rav Acha, M, et al.
Publicado: (2023)

Left Atrial Appendage Occlusion versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation—One-Year Survival
por: Tiosano, Shmuel, et al.
Publicado: (2023)

Evaluation of MADIT II risk stratification score among registry of heart failure patients with primary prevention ICD/CRTD device
por: Rav Acha, M, et al.
Publicado: (2023)

Use of Electrophysiological Studies in Transcatheter Aortic Valve Implantation
por: Tovia-Brodie, Oholi, et al.
Publicado: (2020)

Cryoballoon-Induced Circumferential Pulmonary Vein Fibrosis, Assessed by Late Gadolinium-Enhancement Cardiac Magnetic Resonance Imaging, and Its Correlation with Clinical Atrial Fibrillation Recurrence
por: Rav Acha, Moshe, et al.
Publicado: (2023)

F5. CLOZAPINE RELATED THROMBOCYTOSIS AND THROMBOCYTOPENIA
por: Kang, Yuree, et al.
Publicado: (2018)

Catheter ablation of the slow pathway as a treatment for severe sinus node dysfunction in a patient with incessant atrioventricular nodal reentry tachycardia
por: Margolis, Gilad, et al.
Publicado: (2018)

Heart Rate Variability for Risk Assessment of Myocardial Ischemia in Patients Without Known Coronary Artery Disease: The HRV‐DETECT (Heart Rate Variability for the Detection of Myocardial Ischemia) Study
por: Goldenberg, Ilan, et al.
Publicado: (2019)

Lower hemoglobin transfusion trigger is associated with higher mortality in patients hospitalized with pneumonia
por: Rahimi-Levene, Naomi, et al.
Publicado: (2018)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial
por: Arbel, Yaron, et al.
Publicado: (2016)

Anticoagulant Therapy for Frail Patients with Atrial Fibrillation
por: Hori, Hiroshi, et al.
Publicado: (2021)

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
por: Ko, Darae, et al.
Publicado: (2021)

Hemoglobin transfusion trigger in an internal medicine department – A "real world" six year experience
por: Rahimi-Levene, Naomi, et al.
Publicado: (2018)

Ruxolitinib for Refractory Macrophage Activation Syndrome Complicating Adult-Onset Still’s Disease
por: Levy, Ofer, et al.
Publicado: (2022)

Timing of BNT162b2 vaccine prior to COVID‐19 infection, influence disease severity in patients with hematologic malignancies: Results from a cohort study
por: Gutwein, Odit, et al.
Publicado: (2023)

Anatomical accuracy of the KODEX‐EPD novel 3D mapping system of the left atrium during pulmonary vein isolation: A correlation with computer tomography imaging
por: Tovia Brodie, Oholi, et al.
Publicado: (2022)

The temporal context of oral anticoagulation outcome in atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2022)

Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease
por: Younis, Arwa, et al.
Publicado: (2016)

Physician's Fear of Anticoagulant Therapy in Nonvalvular Atrial Fibrillation
por: Sen, Souvik, et al.
Publicado: (2014)

Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation
por: Reiffel, James A.
Publicado: (2018)

Atrial fibrillation, electroconvulsive therapy, stroke risk, and anticoagulation
por: Kapadia, Meera, et al.
Publicado: (2023)

Association of Guideline-Based Medical Therapy with Malignant Arrhythmias and Mortality among Heart Failure Patients Implanted with Cardioverter Defibrillator (ICD) or Cardiac Resynchronization-Defibrillator Device (CRTD)
por: Hasin, Tal, et al.
Publicado: (2021)

Guideline‐Recommended Therapies and Clinical Outcomes According to the Risk for Recurrent Cardiovascular Events After an Acute Coronary Syndrome
por: Hammer, Yoav, et al.
Publicado: (2018)

Ethnic Disparity in Mortality Among Ischemic Heart Disease Patients. A-20 Years Outcome Study From Israel
por: Abu-Much, Arsalan, et al.
Publicado: (2021)

Comparison of Long-Term Outcomes Between Combination Antiplatelet and Anticoagulant Therapy and Anticoagulant Monotherapy in Patients With Atrial Fibrillation and Left Atrial Thrombi
por: Sunaga, Akihiro, et al.
Publicado: (2020)

Sex-Differences in Atrial Fibrillation Patients: Bias or Proper Management?
por: Israeli, Asaf, et al.
Publicado: (2022)

Trends in Oral Anticoagulation Therapy Among Korean Patients With Atrial Fibrillation: The KORean Atrial Fibrillation Investigation
por: Shin, Hong-Won, et al.
Publicado: (2012)

Marked rebound thrombocytosis in response to glucocorticoids in a patient with acquired amegakaryocytic thrombocytopenia
por: Nishino, Shogo, et al.
Publicado: (2018)

Type of atrial fibrillation and outcomes in patients without oral anticoagulants
por: Ren, Jiameng, et al.
Publicado: (2020)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Anticoagulation for atrial fibrillation in active cancer
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Etiology of Ischemic Strokes of Patients with Atrial Fibrillation and Therapy with Anticoagulants
por: Purrucker, Jan C., et al.
Publicado: (2020)

Treated with preventive anticoagulation therapy in atrial fibrillation: The patients’ perspective
por: Olsson, Karin, et al.
Publicado: (2021)

Challenges of Anticoagulant Therapy in Atrial Fibrillation—Focus on Gastrointestinal Bleeding
por: Scridon, Alina, et al.
Publicado: (2023)

Prescribing Errors With Direct Oral Anticoagulants and Their Impact on the Risk of Bleeding in Patients With Atrial Fibrillation
por: Raccah, Bruria Hirsh, et al.
Publicado: (2021)

Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation
por: Yong, Celina M., et al.
Publicado: (2020)

Thrombocytosis
por: Vitiritti, M
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_e46ni9om4o9condv3hk67eph11